Price Transparency in the Management of Skull Base Tumors-The Price to Operate

颅底肿瘤治疗价格透明度——手术费用

阅读:1

Abstract

Background  Due to the escalating health care costs in the United States, the Centers for Medicare and Medicaid Services (CMS) implemented a cost transparency initiative on January 1, 2021. Hospitals lack functional cost estimators or fail to provide pricing information for common skull base procedures. Methods  A list of the top 70 neurosurgery and otolaryngology hospital systems according to the US News and World Report rankings was made. Google searches for each hospital's cost estimator tool were conducted, recording its presence and accessibility time. Using the cost estimator tool, specific skull base procedure prices, Current Procedural Terminology codes, and contact information for personalized estimates were searched. Results  Fifty-seven hospitals (81%) were privately funded. The majority were urban teaching hospitals ( n  = 68; 97%). Geographical locations included 19 (27%) in the Northeast, 21 (30%) in the Midwest, 20 (29%) in the South, and 10 (14%) in the West. Of the 70 hospitals, 4 (5.7%) did not have a cost estimation website. Of the 66 hospitals that did, the average time to locate the cost of the skull-based procedures was 17.8 seconds (range 12-28 seconds). Only two (2.9%) hospitals had information for skull base procedures; both were radiosurgery procedures. The most common stereotactic radiosurgery offered was gamma knife radiosurgery ( n  = 50; 71%). A total of 19 hospitals (27%) did not include contact information for personalized cost estimation. Conclusion  The CMS price transparency guidelines are not designed to encompass skull base procedures. Due to this ambiguity, patients are unable to make informed financial decisions when selecting treatment options.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。